Calliditas Therapeutics AB (publ)
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Calliditas Therapeutics AB (publ)'s past years’ income statements indicate that its last revenue has increased compared to the previous period by 50% to $1,206,888,000. Profit margin reached -39%. Total operating expenses were $1,514,228,000.

Profit Margin

Calliditas Therapeutics AB (publ) (NASDAQ:CALT): Profit margin
2015 478K -51.01M -10672.38%
2016 0 -56.91M
2017 0 -86.79M
2018 0 -132.04M
2019 184.82M -32.57M -17.63%
2020 874K -436.51M -49944.05%
2021 229.34M -509.53M -222.17%
2022 802.87M -412.26M -51.35%
2023 1.20B -466.18M -38.63%

CALT Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
1.20B802.87M229.34M874K184.82M000478K
Cost of revenue
77.05M15.20M000051K051.38M
Gross profit
1.12B787.67M229.34M874K184.82M0-51K0-50.91M
Operating exp.
Research and development
499.53M414.74M357.48M241.37M149.82M0384K036.89M
Selling and marketing
727.74M515.19M179.60M38.96M00000
Total operating expenses
1.51B1.20B753.80M383.09M212.70M133.19M84.65M56.51M51.38M
Operating income
-384.39M-421.94M-524.45M-379.72M-28.01M-132.48M-84.50M-56.02M-50.91M
Other income (expenses), net
-72.62M12.52M11.08M-53.93M-4.48M1.15M-2.28M611K375K
Income before tax
-457.01M-409.41M-513.37M-436.15M-32.50M-132.04M-86.79M-56.91M-51.01M
Income tax expense
9.16M2.85M-3.83M360K77K441K2.24M1.00M9K
Net income
-466.18M-412.26M-509.53M-436.51M-32.57M-132.04M-86.79M-56.91M-51.01M
Earnings per share
Basic EPS
-8.69-7.78-10.02-9.73-0.88-5.09-5.81-1.71-1.54
Diluted EPS
-8.69-7.78-10.02-9.73-0.88-5.09-5.81-1.71-1.54
Data sourceData sourceData sourceData source